vaccination today. Temporary suspension in the US On 22 March 2010, the detection of DNA from porcine circovirus types 1 and 2 within RotaTeq and Rotarix prompted the FDA to suspend the use of rotavirus vaccines while conducting an investigation the finding of DNA from porcine circovirus-1 (PCV1) in the vaccine in collaboration with the 12 members of the Vaccines and Related Biological Products Advisory Committee (VRBPAC). On 6 May 2010, the FDA announced its decision to revoke the suspension, stating that porcine circovirus types 1 and 2 pose no safety risks in humans and concluded that health risks involved did not offset the benefits of the vaccination. In May 2010 the suspension of the Rotarix vaccine was lifted. Research Doctors Without Borders (MSF) developed a heat-stable version named BRV-PV. Phase 3 of the clinical trials were completed in Niger on 31 December 2020. The vaccine has been associated with lower rates of type 1 diabetes. References Further reading External links Rotavirus , Vaccine Resource Library Gastroenterology Live vaccines Rotaviruses Merck & Co. brands Vaccines Viral diseases Wikipedia medicine articles ready to translate World Health Organization essential medicines (vaccines) fr:Rotavirus#Vaccins